Received: 21 November 2017
Accepted: 16 April 2018
First Online: 27 April 2018
Ethics approval and consent to participate
: This study protocol was approved by an institutional review board (“Sutter Health Institutional Review Board”, San Francisco, CA, USA), and a waiver of patient consent was obtained prior to initiation of the study.
: David R. minor received honoraria from Bristol-Myer Squibb and Merck; Mohammed Kashani-Sabet received research funding from Merck.; Kevin B. Kim received honoraria from Bristol-Myer Squibb, Merck, Novartis and Genentech. Institution received research grant from Bristol-Myer Squibb, Merck and Novartis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.